Arbutus Biopharma (ABUS) Other Non Operating Income (2016 - 2025)
Historic Other Non Operating Income for Arbutus Biopharma (ABUS) over the last 17 years, with Q3 2025 value amounting to -$12000.0.
- Arbutus Biopharma's Other Non Operating Income fell 34000.0% to -$12000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$20000.0, marking a year-over-year decrease of 90000.0%. This contributed to the annual value of -$49000.0 for FY2024, which is 29600.0% down from last year.
- According to the latest figures from Q3 2025, Arbutus Biopharma's Other Non Operating Income is -$12000.0, which was down 34000.0% from $21000.0 recorded in Q2 2025.
- Over the past 5 years, Arbutus Biopharma's Other Non Operating Income peaked at $28000.0 during Q1 2021, and registered a low of -$33000.0 during Q4 2024.
- Moreover, its 5-year median value for Other Non Operating Income was $2000.0 (2022), whereas its average is -$1555.6.
- Its Other Non Operating Income has fluctuated over the past 5 years, first skyrocketed by 45000.0% in 2023, then crashed by 90000.0% in 2024.
- Over the past 5 years, Arbutus Biopharma's Other Non Operating Income (Quarter) stood at $5000.0 in 2021, then tumbled by 180.0% to -$4000.0 in 2022, then surged by 450.0% to $14000.0 in 2023, then plummeted by 335.71% to -$33000.0 in 2024, then skyrocketed by 63.64% to -$12000.0 in 2025.
- Its last three reported values are -$12000.0 in Q3 2025, $21000.0 for Q2 2025, and $4000.0 during Q1 2025.